References
- M. Ferrari, Cancer nanotechnology: opportunities and challenges. Nat RevCancer 5, 161–71 (2005).
- D. Jones, Cancer nanotechnology: small, but heading for the big time. Nat RevDrug Discov. 6, 174–5 (2007).
- D. Peer, J. M. Karp, S. Hong, O. C. FaroKhzad, R. Margalit, and R. Langer, Nanocarriers asan emerging platform for cancer therapy. Nat Nanotechnol. 2, 751–60 (2007).
- I. H. El-Sayed, X. H. Huang, and M. A. El-Sayed, Surface plasmon resonance scatteringand absorption of anti-EGFR antibody conjugated gold nanoparticles in cancerdiagnostics: applications in oral cancer. Nano Lett. 5, 829–34 (2005).
- J. H. Lee, Y. M. Huh, Y. Jun, J. Seo, J. Jang, and H. T. Song, et al., Artificially engineeredmagnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med. 13, 95–9 (2007).
- X. M. Jiang, T. L. Ward, Y. S. Cheng, J. W. Liu, and C. J. Brinker, Aerosol fabrication of hollow mesoporous silica nanoparticles and encapsulation of L-methionine asa candidate drug cargo. Chem Commun. 46, 3019–21 (2010).
- J. Kim, H. S. Kim, N. Lee, T. Kim, H. Kim, and T. Yu, et al., Multifunctional uniformnanoparticles composed of a magnetite nanocrystal core and a mesoporoussilica shell for magnetic resonance and fluorescenceimaging and for drugdelivery. Angew Chem Int Ed. 47, 8438–41 (2008).
- Y. Chen, C. Chu, and Y. Zhou, et al., Reversible Pore‐Structure Evolution in Hollow Silica Nanocapsules: Large Pores for siRNA Delivery and Nanoparticle Collecting. Small, 7, 2935–2944 (2011).